New Drug Application Submitted To FDA For Investigational Analgesic Tapentadol Immediate Release Tablets

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tapentadol hydrochloride immediate release (IR) tablets, an investigational oral analgesic for the relief of moderate to severe acute pain.

More: continued here

Filed under: Pain / Anesthetics on January 29th, 2008